AHIVX Performance — High Income Fund, Investor Class
Data updated: 2026-08-28
AHIVX returned +1.65% year to date and +5.84% over one year to Jun 2026. Annualised returns are +8.37% over 3 years and +3.87% over 5 years. The fund beat its Short-Term Corporate Bond category average: $100 invested three years ago grew to $127, against $121 for the category, and to $106 over one year, against $105. Volatility over the past three years was 4.46% a year. In the 12 months to Jun 2026 the fund lost a net $82.1M, and assets reached $1.89B.
AHIVX Growth of $100
What $100 invested in High Income Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Short-Term Corporate Bond category average over the same months.
| Period | AHIVX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $106 | $105 |
| 3 years (Jul 2023 – Jun 2026) | $127 | $121 |
| 5 years (Jul 2021 – Jun 2026) | $121 | $117 |
| Since data start (Jul 2019 – Jun 2026) | $141 | $128 |
AHIVX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +1.65% |
| 1 year | +5.84% |
| 3 years (annualised) | +8.37% |
| 5 years (annualised) | +3.87% |
AHIVX Annual Returns
Calendar-year total returns of High Income Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +1.65% |
| 2025 | +8.58% |
| 2024 | +7.36% |
| 2023 | +13.61% |
| 2022 | −11.38% |
| 2021 | +6.21% |
| 2020 | +7.88% |
| 2019 (Jul–Dec) | +3.48% |
AHIVX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.4% | +0.3% | −1.4% | +1.7% | +0.4% | +0.2% | — | — | — | — | — | — |
| 2025 | +1.4% | +0.7% | −1.2% | −0.1% | +1.6% | +1.9% | +0.4% | +1.3% | +0.9% | +0.1% | +0.7% | +0.7% |
| 2024 | 0.0% | +0.2% | +1.2% | −1.0% | +1.1% | +0.8% | +1.8% | +1.5% | +1.6% | −0.7% | +1.2% | −0.5% |
| 2023 | +4.1% | −1.4% | +1.3% | +1.0% | −1.0% | +1.8% | +1.4% | +0.3% | −1.3% | −1.4% | +4.7% | +3.7% |
| 2022 | −2.6% | −0.8% | −0.9% | −3.7% | 0.0% | −7.2% | +6.0% | −2.2% | −4.1% | +2.7% | +2.5% | −1.0% |
| 2021 | +0.4% | +0.8% | +0.6% | +1.1% | +0.3% | +1.4% | +0.1% | +0.5% | +0.1% | −0.1% | −1.2% | +1.9% |
| 2020 | −0.1% | −1.5% | −11.1% | +3.6% | +4.5% | +1.0% | +4.7% | +1.6% | −1.0% | +0.3% | +4.5% | +2.2% |
| 2019 | — | — | — | — | — | — | +0.5% | +0.3% | +0.3% | +0.1% | +0.2% | +1.9% |
AHIVX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 4.46%
- 3-year Sharpe ratio: 0.87 (vs 4.5% risk-free rate)
- Best month: +4.68% (Nov 2023)
- Worst month: −1.41% (Oct 2023)
AHIVX Fund Flows
Monthly money in and out of High Income Fund, from SEC Form N-PORT.
- 12-month net flow: −$82.1M
- 12-month gross sales (incl. reinvestments): $534.6M
- Sales ÷ redemptions: 0.87×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $50.0M | $25.0M | $25.0M |
| May 2026 | $43.0M | $23.3M | $19.8M |
| Apr 2026 | $16.5M | $20.0M | −$3.5M |
| Mar 2026 | $54.9M | $65.0M | −$10.1M |
| Feb 2026 | $37.2M | $51.5M | −$14.4M |
| Jan 2026 | $33.9M | $35.9M | −$2.0M |
| Dec 2025 | $79.5M | $67.0M | $12.5M |
| Nov 2025 | $44.6M | $32.8M | $11.8M |
| Oct 2025 | $32.2M | $59.9M | −$27.7M |
| Sep 2025 | $70.5M | $159.3M | −$88.8M |
| Aug 2025 | $27.6M | $41.5M | −$13.9M |
| Jul 2025 | $44.7M | $35.5M | $9.1M |
AHIVX Assets Under Management
Net assets of High Income Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.89B |
| 2026-03-31 | $1.83B |
| 2025-12-31 | $1.90B |
| 2025-09-30 | $1.91B |
| 2025-06-30 | $1.98B |
| 2025-03-31 | $1.91B |
| 2024-12-31 | $2.20B |
| 2024-09-30 | $2.31B |
| 2024-06-30 | $2.21B |
| 2024-03-31 | $2.17B |
| 2023-12-31 | $2.17B |
| 2023-09-30 | $1.96B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.